The study indicated that anlotinib may treat ATC by inducing ferroptosis, and the autophagy-ferroptosis signaling pathway may offer a synergistic combination treatment strategy
*Correspondence: Masayuki Yamamoto, Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
The dual-hormone idea behind CagriSema CagriSema is a fixed-dose combination of cagrilintide 2.4 mg, a long-acting amylin analogue, and semaglutide 2.4 mg, the GLP-1 receptor agonist already familiar as the active ingredient in Wegovy and Ozempic
Liu WJ, Jin HY, Lee KA, Xie SH, Baek HS, Park TS (2011) Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
Data analysis was performed using suitable software